Cost and availability of novel cell and gene therapies: Can we avoid a catastrophic second valley of death?

Cost and availability of novel cell and gene therapies: Can we avoid a catastrophic second valley of death?

Graphical Abstract Advanced gene and cellular therapies risk a second “valley of death” due to their high costs and low patient population. As these are life‐saving therapies, measures are urgently needed to prevent their withdrawal from the market.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:EMBO reports 2023-02, Vol.24 (2)
Hauptverfasser: De Luca, Michele, Cossu, Giulio
Format: Artikel
Sprache:eng
Schlagworte:
EMBO08
EMBO16
EMBO49
Gene therapy
Life Sciences
Science & Society
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Graphical Abstract Advanced gene and cellular therapies risk a second “valley of death” due to their high costs and low patient population. As these are life‐saving therapies, measures are urgently needed to prevent their withdrawal from the market.
ISSN:1469-221X
1469-3178
DOI:10.15252/embr.202256661